Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115525) titled 'fMRI-guided personalized TMS intervention for early Alzheimer's disease: a multicenter, double-blind, randomized, controlled trial on efficacy and mechanisms' on Dec. 28, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Affiliated Hospital of Hangzhou Normal University
Condition:
Alzheimers disease
Intervention:
EF-guided group:Employing the iTBS paradigm, individualised superficial cortical stimulation targets were calculated using GCA-fMRI. The resting motor threshold was set at 100%. Stimulation duration was 2 seconds, with an 8-second interstimulus interval. Each session c...